Device Trial Radar · NCT02447133
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
Last checked: Nov 19, 2026Latest source record: Jun 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
May 2015
Primary completion
May 2015
Study completion May 2015
Sponsor
- Lead sponsor
- Topcon Medical Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.
Conditions
- Subjects Presenting With Normal Eyes
Interventions
3D OCT-1 MaestroDevice
OCT Machine used for diagnostic purposes
Primary outcomes
What the sponsor says the trial is designed to measure.
- TopQ Cut OffTime frame: 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Topcon Medical Systems, Inc.
Oakland, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.